###begin article-title 0
###xml 45 50 <span type="species:ncbi:9606">human</span>
Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 416 424 <span type="species:ncbi:9606">patients</span>
To evaluate the role of nerve growth factor (NGF) in remodeling processes of vernal keratoconjunctivitis (VKC). VKC is a chronic inflammatory disorder of the conjunctiva and is characterized by marked tissue remodeling. NGF, a pleiotrophic factor with documented profibrogenic activities, is produced by inflammatory and structural cells populating the VKC conjunctiva and is increased in the serum and tears of VKC patients.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
Primary cultures of VKC-derived fibroblasts (VKC-FBs) were exposed to increasing NGF concentrations (1-500 ng/ml) to evaluate and compare the expression of alpha-smooth muscle actin (alphaSMA, a defining myofibroblast marker), collagens (types I and IV), and metalloproteinases and tissue inhibitors (MMP9/TIMP1, MMP2/TIMP2) at the biochemical as well as molecular levels.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 237 241 229 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 249 252 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 291 295 283 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 419 422 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
Endogenous NGF was increased in the VKC-FB supernatant, as compared to healthy-FB supernatant. VKC-FBs expressed alphaSMA and increased types I and IV collagens. VKC-FBs, and in particular all alphaSMA positive cells, expressed both trkANGFR and p75NTR, while healthy-FBs only expressed trkANGFR. Exogenous NGF did not change alphaSMA expression, while alphaSMA expression was enhanced by specific neutralization of p75NTR. NGF (10 ng/ml) exposure significantly decreased type I collagen expression, without affecting type IV collagen, and increased MMP9mRNA and protein.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
The autocrine modulation of differentiation and response of VKC-FBs to NGF exposure with downregulation of type I collagen and upregulation of MMP9 expression supports a relevant role for NGF in tissue remodeling of VKC.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 1027 1028 1027 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Vernal keratoconjunctivitis (VKC) is a severe chronic inflammatory disease of the conjunctiva. The disease is characterized by an allergic phenotype with infiltration of lymphocytes (mostly Th2), eosinophils, and mast cells [1]. In VKC, Th2 inflammation is associated with marked tissue remodeling as shown by fibroblast (FBs) activation, epithelial growth, subepithelial fibrosis, and extracellular matrix (ECM) deposition, resulting in giant papillae formation [2]. ECM analysis has shown a substantial increase in total collagen (procollagen and types I, III, and IV collagen), with an altered collagen ratio, both in tears and conjunctiva [3].Increased ECM is referred to increased expression of cytokines and growth factors, from either Th2-type and other inflammatory cells, which are known to stimulate resident/activated FBs to overproduce ECM [4]. Overt production and deposition of ECM eventually results from an unbalance between collagen production and Matrix Metalloproteinases (MMP1, MMP2 and MMP9) activities [1,3].
###end p 10
###begin p 11
###xml 288 289 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 290 291 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 396 397 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
A variety of inflammatory- and stromal-derived cytokines, such as TNF-alpha, IL-1, IL-4, IL-13, and IL-6, and growth factors, such as transforming growth factor beta1 (TGFbeta1) have been reported to cause chronic inflammation, structural changes, tissue remodeling, as well as fibrosis [5,6]. All these factors are increased in the peripheral blood, tears, and conjunctiva of patients with VKC [2].
###end p 11
###begin p 12
###xml 361 362 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 363 364 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 461 462 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 442 450 <span type="species:ncbi:9606">patients</span>
To date, TGFbeta1 represents the main profibrogenic factor responsible for the imbalance in ECM metabolism as well as for the chemoattraction and survival of FBs and myoFBs. Interestingly, nerve growth factor (NGF) has been recently prospected as another factor playing a role in stromal-epithelial interaction during wound-healing and tissue repair processes [7,8]. Certainly, NGF is significantly increased in both serum and conjunctiva of patients with VKC [9].
###end p 12
###begin p 13
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
We previously reported a profibrogenic NGF effect on in vitro primary cultures of healthy conjunctival FBs (healthy-FBs) [8]. Since nothing is known about the possible role of NGF (increased in VKC-affected conjunctiva) on primary cultures of VKC conjunctival FBs (VKC-FBs), we exposed these cells to increasing NGF concentrations. In addition, some in vitro parameters of tissue remodeling were evaluated.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Reagents
###end title 15
###begin p 16
Unless otherwise noted, sterile tissue culture plastic-ware and analytical grade reagents were from NUNC (Roskilde, Denmark), SERVA (Weidelberg, Germany), ICN (Costa Mesa, CA), Euroclone (Milan, Italy), and Invitrogen-Gibco (Paisley, UK).
###end p 16
###begin title 17
Cell culture and experimental procedure
###end title 17
###begin p 18
###xml 187 194 <span type="species:ncbi:9606">patient</span>
###xml 873 881 <span type="species:ncbi:9606">patients</span>
FBs were isolated from the upper tarsal VKC (n=3; 3M, range 11-15, mean age 12.67+/-2.08) and sex/age matched healthy (n=3) conjunctiva. Informed consent was given by the parents of each patient and the approval of the Intramural Ethic Committee was granted, in conformity to the Declaration of Helsinki. The diagnosis of active VKC was based on history, clinical examination and the presence of eosinophils in conjunctival biopsy. Clinical scores (0-3: 0, absent; 1, weak; 2, mild; 3, severe) for each ocular symptom (itching, tearing, photophobia and foreign body sensation) and each sign (conjunctival hyperemia, mucous discharge, papillae and corneal epithelial erosion) were assigned at the time of examination. Total symptom (range 0-3) and sign scores (0-12) were calculated showing: total symptom score of 7.33+/-4.51 and total sign score of 8.67+/-3.05. The three patients showing lid-ptosis were submitted to surgical removal of the papillae that were processed in this study.
###end p 18
###begin p 19
###xml 287 288 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 628 629 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 774 776 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 152 158 <span type="species:ncbi:9913">Bovine</span>
Biopsies were put as explants in 24-well plates and left to attach for 10 min, before adding medium (DMEM) supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 2 mM glutamine, 100 U/ml penicillin and 100 mug/ml streptomycin. Cells outgrowing from biopsies (37 degreesC, 5% CO2 in air, by 1 week), were quickly trypsinized (0.2% trypsin/0.025% EDTA), assessed for the absence of epithelial cell contaminants (cytokeratin 19, 1:100; Dako Corp., Carpinteria, CA) and screened as mycoplasm free cultures (otherwise treated for 1 generation with 5 mug/ml Mycoplasm Removal Agent; ICN). FBs were sub-cultured (T-21/T-75 cm2 flasks) and used for the experiments (3rd to 4th passage) after 3 h of serum starvation (synchronization and reduction of autophosphorylation) [10].
###end p 19
###begin p 20
###xml 169 171 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 202 203 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 437 441 426 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 490 493 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 702 703 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 704 706 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
For the specific experiments, confluent FBs were treated with increasing NGF concentrations (murine betaNGF; 1-500 ng/ml; produced according to a standardized protocol [11]) in minimal DMEM (0.5% FBS) [8]. Biochemical and molecular evaluations were performed 2 days after stimulation. For blocking experiments, serum-starved FBs were preincubated for 1 h with 500 ng/ml alphaNGF (R&D Systems, Minneapolis, MN) or with 100 ng/ml alphatrkANGFR (Calbiochem, La Jolla, CA) or 100 ng/ml alphap75NTR (Calbiochem) specific neutralizing antibodies, before the addition of NGF alone (untreated FBs) or in the same blocking reagents (pretreated FBs), for two days. Whenever required and according to literature [6,12], human TGFbeta1 (1-10 ng/ml, R&D) was used as positive control in some experiments.
###end p 20
###begin title 21
Confocal microscopy
###end title 21
###begin p 22
###xml 274 275 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 502 506 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 583 586 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 781 782 773 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 365 <span type="species:ncbi:9913">bovine</span>
###xml 480 486 <span type="species:ncbi:9986">rabbit</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 564 568 <span type="species:ncbi:9925">goat</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:9606">human</span>
Confluent monolayers (on sterilized round glasses, EMS, Hatfield, PA) were washed in Hank's Balanced Sodium Salt (HBSS), fixed in 2% rho-formaldehyde (PFA) - 0.1 M Phosphate Buffer (PB), rinsed in 10 mM PB - 137 mM NaCl (phosphate buffered saline, PBS), quenched in 50 mM NH4Cl-PBS, permeabilized in 0.5% Triton X-100 PBS (TX-PBS) and finally blocked in 0.8% bovine serum albumin (BSA)-PBS. Monolayers were then probed with the following antibodies in 0.05% Tween20-PBS (TW-PBS): rabbit anti-human trkANGFR antibody (2 mug/ml; Santa Cruz Biotech, Santa Cruz, CA); goat anti-human p75NTR antibody (2 mug/ml; Santa Cruz) and mouse anti-human alphaSMA antibodies (1/50; Novocastra, Milan, Italy). Specific binding of the primary antibody was detected using Cy2 or Cy3 conjugated F(ab)2 antibodies in TW-PBS (Jackson Laboratories, West Grove, PA). Control immune-staining was performed by substituting primary antibodies with control irrelevant IgG (Vector Laboratories, Burlingame, CA). Glasses were mounted on slides using an anti-fade medium (Vectashield, Vector) and viewed with a confocal inverted microscope (E2000U; Nikon, Tokyo, Japan). Images and brightness/contrast levels were captured/evaluated using the C1 software (Nikon) and the Adobe Photoshop 7.0 program (Adobe Systems Inc., San Jose, CA), respectively.
###end p 22
###begin title 23
Relative real-time RT-PCR
###end title 23
###begin p 24
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 130 133 125 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 140 143 130 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">280</sub>
###xml 1148 1152 1086 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 1271 1274 1203 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1902 1903 1806 1807 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 2064 2066 1966 1968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
Total RNA (1x106 cells) was extracted in OMNIzol (Euroclone), DNaseI treated (AB1709; Ambion Inc., Austin, TX), quantified (lambda260/lambda280 >1.8) and checked for RNA integrity. Three mug total RNA were reverse transcripted (Mu-MLV; Finnzyme, Milan, Italy) in a PTC-100 programmable thermocycler (MJ Research, Watertown, MA). cDNAs (3 mul for target gene and 1 mul for referring gene) were amplified using the Opticon2 real time termocycler (MJ Research) in a 20 mul final volume of SYBR Green PCR mixture (Applied Biosystems, Foster City, CA). The temperature profile included initial 95 degreesC for 15 min incubation, followed by 35-47 cycles of denaturation at 95 degreesC for 30 s, annealing at 55-60 degreesC for 25 s (see previous paragraph for specific Ta), elongation at 72 degreesC for 30 s, fluorescence monitoring at 60-90 degreesC, 0.01 degreesC for 0.3 s, and further incubation at 72 degreesC for 5 min. PCR amplification primer pairs were received from  or  (MWG Biotech, Ebersberg, Germany), were as follows: NGF (forward: CTG GCC ACA CTG AGG TGC AT; reverse: TCC TGC AGG GAC ATT GCT CTC; 120 bp; 53 degreesC Ta; Genbank ); trkANGFR (forward: CAT CGT GAA GAG TGG TCT CCG; reverse: GAG AGA GAC TCC AGA GCG TTG AA; 102 bp; 58 degreesC Ta; Genbank ); p75NTR (forward: CCT ACG GCT ACT ACC AGG ATG AG; reverse: TGG CCT CGT CGG AAT ACG; 147 bp; 57 degreesC Ta; Genbank ); alphaSMA (forward: GAA GGA GAT CAC GGC CCT A; reverse: ACA TCT GCT GGA AGG TGG AC; 125 bp; 60 degreesC Ta; Genbank ); MMP-9 (forward: CAG TCC ACC CTT GTG CTC TTC C; reverse; GCC ACC CGA GTG TAA CCA TAG C; 113 bp; 60 degreesC Ta; Genbank ) and the referring GAPDH gene (forward: GAA GGG GTC ATT GAT GGC AAC; reverse: GGG AAG GTG AAG GTC GGA GTC; 100 bp; 53 degreesC Ta; Genbank ). Product specificity was assessed by melting curve analysis of each sample carried out in duplicate as well as by gel size-fractioning. Ct values normalized samples showing good melting curves were used for statistical analysis. Differences in PCR product expression were evaluated by (c) software [13].
###end p 24
###begin title 25
Proliferation assays
###end title 25
###begin p 26
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 344 350 <span type="species:ncbi:9986">rabbit</span>
The effect of increasing NGF concentration on VKC-FB proliferation was investigated by counting the cells, after brief enzymatic digestion, using the trypan blue exclusion test. The expression of the nuclear proliferating factor ki67, recognizing all the cell cycles except G0 [14], was investigated on previously fixed monolayers stained with rabbit antihuman ki67 antibody (1:1000, Santa Cruz) and developed by fluorescent ABC technique (Vector).
###end p 26
###begin title 27
Nerve growth factor ELISA
###end title 27
###begin p 28
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 670 677 641 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450-550</sub>
###xml 856 858 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
To evaluate NGF in the supernatants of VKC and healthy FBs, we carried out a a two-site NGF ELISA (sensitivity=0.5 pg/ml) [15]. In brief, 96-well Maxisorp ELISA plates were precoated with monoclonal antihuman betaNGF antibodies (0.4 mug/ml; MAB256, RalphaD). Both standards (0.15 pg/ml to 1 ng/ml betaNGF; Alomone, Jerusalem, Israel) and samples (1/4) were incubated at 4 degreesC for 18 h. ELISA was developed by using polyclonal biotinylated antihuman etaNGF antibodies (0.15 mug/ml, 500-P85Bt; Peprotech, Milan, Italy), HRP-streptavidin (1/300; DY998, RalphaD) and the ready-to-use TMB substrate (Zymed, San Francisco, CA). Optical density (OD) was measured at lambda450-550 by a microplate ELISA reader (Sunrise, Tecan Systems, Inc., San Jose, CA). The biological activity of FB-derived NGF was tested separately by using a standardized PC12 bioassay [16]. Protein normalization was achieved by a Bio-Rad protein assay, using BSA equivalent as a standard (Bio-Rad Laboratories, Inc., Hercules, CA).
###end p 28
###begin title 29
Cell surface ELISA
###end title 29
###begin p 30
###xml 108 110 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 131 132 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 328 329 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 390 391 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 392 393 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To investigate the effect of NGF on alphaSMA expression by VKC-FBs, an ELISA was carried out on monolayers [17]. Briefly, FBs (5x105/0.20 ml) were seeded on 96-well plates. Once the cells reached confluence, they were incubated with increasing NGF concentrations. After culturing, plates were washed in HBSS containing 0.1% CaCl2, PFA post-fixed, quenched for endogenous peroxidases (0.3% H2O2 in PBS for 15 min), permeabilized in TX-PBS, and dehydrated with 95% ethanol before the assay. The plates were subsequently processed for quantification of alphaSMA (1/500, Novocastra), types I and type IV collagen (1/1000; Santa Cruz) proteins, using monoclonal and polyclonal specific antibodies diluted in TW-PBS. Biotin-conjugated antimouse or antigoat antibodies and HRP-streptavidin (1/10000 and 1/7000, respectively; Zymed) specific binding were developed with a ready-to-use TMB and quantified using an ELISA reader.
###end p 30
###begin title 31
Western blot analysis
###end title 31
###begin p 32
Total proteins were extracted by 30 min incubation with cold lysis-buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.1% SDS, 7 mug/ml aprotinin, and 1 mM PMSF). Equivalent protein amounts (40-80 mug; Bio-Rad protein assay) were boiled for 5 min under reducing conditions and fractionated on a 4% stacking/6-15% gradient resolving gel at 160 V/60 min (Miniprotean3 apparatus, Bio-Rad). Electrophoresed proteins were transferred to Hy-bond membranes using a semi-dry blotting apparatus (12 V/45 min, Bio-Rad). A molecular weight marker (6-210 kDa; SERVA) was run in parallel. Transferred proteins (Ponceau S staining) were probed at 4 degreesC for 18 h with primary antibodies diluted in TW-PBS (alphaSMA, types I and type IV collagen: 0.2 mug/ml; MMP9: 0.4 mug/ml), labeled with secondary POD-conjugated specific antibodies (1/7000, 90 min; Jackson), and developed by ECL technique (SuperSignal West Pico Trial; Pierce, Rockford, IL) in a high performance Kodak imager station (Kodak 550, Eastman Kodak Company, Scientific Imaging Systems, Rochester, NY). Bands were digitally captured using the 1D Kodak Image Analysis Software, subjected to densitometric analysis, and processed in Adobe Photoshop 7.0. Membranes were stripped at 56 degreesC for 45 min in 1 M Tris-HCl containing 2% SDS and 1.25 mM beta-mercaptoethanol and reprobed with GAPDH antibodies (0.2 mug/ml; Abcam, Cambridge, UK), to verify equal protein loading.
###end p 32
###begin title 33
SDS-PAGE zymography
###end title 33
###begin p 34
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 764 765 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 492 497 <span type="species:ncbi:9606">human</span>
After culturing, the conditioned media were collected and clarified by centrifugation. MMP activity was analyzed by zymography, using a procedure described in reference [18]. Briefly, 50 mul conditioned media were mixed with SDS sample buffer, without beta-ME, and heated for 37 degreesC/30 min. Normalized samples (30 mug/lane; Bio-Rad protein assay) underwent standardized electrophoresis in 10% SDS-PAGE containing 0.1% gelatin (Bio-Rad). Molecular weight markers (6-210 kDa), recombinant human latent MMP9 (92 kDa), and active MMP9 (83 kDa; Calbiochem) were loaded as positive controls. The gel was washed in 2.5% TX-PBS to remove SDS and renature the proteins, incubated at 37 degreesC for 48 h in an activation buffer (50 mM Tris-HCl, 200 mM NaCl, 10 mM CaCl2; pH 7.5), rinsed in ddw, and finally stained for 60 min with 0.25% Coomassie brilliant blue R250 in 40% isopropanol. Gelatinolytic activity was identified as clear bands on a uniform blue background following destaining in 7% acetic acid, indicating the area where gelatin was digested.
###end p 34
###begin title 35
Statistics
###end title 35
###begin p 36
###xml 216 218 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
All experiments were done three times, with each point carried out in duplicate. Experimental results are expressed as mean+/-SEM. Parametric ANOVA followed by Tukey-Kramer post hoc was employed to analyze the data [19], using the statistical package StatView II for PC (Abacus Concepts Inc., Barkley, CA). A probability of less than or equal to 0.05 was considered to be statistically significant.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
Vernal keratoconjunctivitis-derived fibroblasts express nerve growth factor, trkANGFR, p75NTR, and alphaSMA
###end title 38
###begin p 39
###xml 274 283 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 356 360 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 368 371 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 415 419 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 445 446 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 449 460 445 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A,B</xref>
###xml 823 826 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 828 837 812 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1C</xref>
Increased NGF levels were detected by specific ELISA in the conditioned media of VKC-FBs and compared to healthy-FBs (563.33+/-35.12 pg/ml versus 445.67+/-10.59 pg/ml; 26.51% increase; p=0.005). This data is in accordance with the NGF mRNA upregulation observed in VKC-FBs (Figure 1A). RT-PCR and confocal analysis revealed that VKC-FBs expressed both trkANGFR and p75NTR. In contrast, healthy FBs only express trkANGFR, as previously reported [8] (Figure 1A,B). A slight downregulation of trkAmRNA expression was found in VKC-FBs, in comparison to healthy ones (p<0.05). As detected by cs-ELISA, a significant increase of alphaSMA expression was observed in VKC-FBs (0.378+/-0.027 OD VKC-FBs versus 0.232+/-0.046 OD healthy-FBs; a 1.62-protein increase [p<0.01]). VKC-FBs expressed alphaSMA protein in association with p75NTR (Figure 1C). No proliferation was observed in the presence of increasing NGF concentrations (data not shown).
###end p 39
###begin p 40
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 114 115 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 205 209 201 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 223 226 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 425 426 421 422 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 512 515 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 535 539 531 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 557 560 553 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 569 573 565 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 645 646 641 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 736 739 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 781 784 773 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
Nerve growth factor, trkANGFR, p75NTR and alphaSMA expression by vernal keratoconjunctivitis-derived fibroblasts. A: Conventional RT-PCR. showing from left to right, nerve growth factor (NGF; 120 bp), trkANGFR (103 bp); p75NTR (100 bp) amplicons. The lines are as follows: (1) -RT, (2) healthy-FBs, and (3) VKC-FBs. These are representative gels from three independent experiments where equal amounts of cDNA were amplified. B: Confocal microscopy on VKC-FBs showing, from left to right, that VKC-FBs express p75NTR (Cy3, red) and trkANGFR (Cy2, green). p75NTR and trkANGFR colocalized in some cellular compartments (merge; X600/oil immersion). C: Confocal microscopy on VKC-FBs showing, from left to right, that these cells express p75NTR (Cy3, red) and alphaSMA (Cy2, green). p75NTR and alphaSMA colocalized in some cellular compartments (merge; X600/oil immersion).
###end p 40
###begin title 41
Nerve growth factor does not modulate alphaSMA expression
###end title 41
###begin p 42
###xml 253 261 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 381 385 369 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 464 467 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 569 577 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 680 681 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
VKC-FBs were exposed to increasing NGF concentrations (1-500 ng/ml) in order to investigate whether NGF was able to influence alphaSMA expression. At both cs-ELISA and western blot analysis, NGF was not able to influence alphaSMA expression in VKC-FBs (Figure 2; dark bars [p>0.05]). NGF stimulation did not influence alphaSMA expression after preincubations with neutralizing trkANGFR antibodies, (data not shown). In contrast, preincubation with neutralizing p75NTR antibodies followed by increasing NGF concentrations resulted in an increase of alphaSMA expression (Figure 2; light bars [p<0.05]). The pattern of alphaSMA expression resembled those of NGF-treated healthy FBs [8].
###end p 42
###begin p 43
###xml 179 182 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 307 311 286 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
alphaSMA expression by vernal keratoconjunctivitis-derived fibroblasts. Increasing NGF concentrations did not influence alphaSMA expression by VKC-FBs (dark bar; p>0.05). alphap75NTR neutralization (1 mug/ml/30 min) significantly increased alphaSMA expression by NGF-treatment (light bar; p<0.05). alphatrkANGFR neutralization did not influence alphaSMA expression by NGF treated VKC-FBs (data not shown). Representative data from three independent experiments, which results are shown as mean OD+/-SEM.
###end p 43
###begin title 44
Nerve growth factor modulates types I and IV collagen expression
###end title 44
###begin p 45
###xml 264 271 252 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 407 416 395 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 560 569 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 679 688 667 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
In VKC-FBs, the high amount of alphaSMA was found associated with a high rate of types I and IV collagen (rate; 7.78: type I, 1.323+/-0.248 and type IV, 0.170+/-0.004), as compared to healthy FBs (type I, 0.993+/-0.001 and type IV, 0.077+/-0.014; p<0.05; see also Table 1). After NGF exposure, the expression of type I collagen by VKC-FBs was significantly decreased at all the concentration levels tested (Figure 3A). The maximum effect was observed at 10 ng/ml (1.33-target gene decrease, p<0.05), reaching a level almost comparable to those of healthy-FBs (Figure 3A; light bar). By contrast, the expression of type IV collagen was not changed at any NGF concentration level (Figure 3B; light bars).
###end p 45
###begin title 46
Biochemical and molecular description of healthy and vernal keratoconjunctivitis-derived fibroblasts.
###end title 46
###begin p 47
Biochemical and molecular description of healthy and vernal keratoconjunctivitis-derived fibroblasts.
###end p 47
###begin p 48
###xml 258 259 258 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 378 379 378 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Nerve growth factor modulates type I and type IV collagen expression. VKC-FBs showed high types I and IV collagen production in comparison to healthy-FBs (rate: 7.78; p<0.05). Increasing NGF concentrations significantly decreased type I collagen expression (A), with a maximum at 10 ng/ml NGF (1.33 fold decrease; p<0.05). No effect was observed on type IV collagen expression (B). Representative data from three independent experiments are shown as mean OD+/-SEM.
###end p 48
###begin title 49
Nerve growth factor modulates MMP-9 expression and function
###end title 49
###begin p 50
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 504 513 504 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4A</xref>
###xml 664 673 664 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 904 913 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4C</xref>
###xml 1222 1223 1215 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 1318 1325 1311 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
The expression and functional activities of MMP9, known to drive specifically collagen type IV cleavage [20], was investigated as a function of NGF stimulation in VKC-FBs. VKC-FBs were exposed to increasing NGF concentrations (1-100 ng/ml) and the expression of MMP9 protein and mRNA were evaluated and compared to untreated VKC-FBs. By western blot analysis, it was determined that NGF significantly increased MMP9 protein expression in VKC-FBs, as compared to healthy-FBs, in a dose-dependent fashion (Figure 4A). This specific MMP9 increase was associated with an increase of MMP9 activities, as shown by gelatinolytic bands, at the same concentrations tested (Figure 4B). In agreement with biochemical data, the molecular analysis showed that NGF was able to trigger the MMP9-mRNA expression in a dose-dependent fashion with the maximum expression at 10 ng/ml NGF (3.92-target gene increase, p<0.05; Figure 4C). Interestingly, the MMP9-mRNA increasing effect of 10 ng/ml NGF was found to be comparable to that of 1 ng/ml TGFbeta1 (5.48+/-0.04 versus 7.49+/-0.09, respectively). According to the literature, MMP9 mRNA was found to be increased in VKC-FBs as compared to healthy-FBs (24.98-target gene increase; p<0.05 [3]). Biochemical and molecular characteristics of healthy and VKC-derived FBs are summarized in Table 1.
###end p 50
###begin p 51
###xml 183 184 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 483 484 481 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 733 734 727 728 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 956 958 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Nerve growth factor increases MMP9 expression and function by vernal keratoconjunctivitis-derived fibroblasts. Conditioned media were collected and processed as described in Methods. A: The histogram shows a significant increase of MMP9 protein expression in VKC-FBs treated with increasing NGF concentrations, according to the densitometric analysis (mean OD+/-SEM; p<0.05). Data were normalized to GAPDH expression and presented as fold increase with respect to untreated VKC-FBs. B: The functional activity in MMP9 was investigated by SDS-PAGE zymography. From left to right (1-6 lines): 0, 1, 10, 100, 250, 500 ng/ml NGF; line 7, alphaNGF+100 ng/ml NGF. Panel represents one of three independent gels that gave the same results. C: Relative real-time PCR showed a significant increase of MMP9 mRNA expression in VKC-FBs treated with different concentrations of NGF (p<0.05). Data were normalized to GAPDHmRNA expression and presented as fold increase [11] with respect to untreated VKC-FBs.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
Our data demonstrated that primary cultures of VKC-FBs express both trkANGFR and p75NTR receptors and produce high levels of NGF, types I and IV collagens, and MMP9. Moreover, VKC-FBs are mainly represented by myoFBs, since a consistent proportion of VKC-FBs were alphaSMA positive.
###end p 53
###begin p 54
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 632 634 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Various Th2-derived cytokines and growth factors are increased in blood, tears, and conjunctiva from VKC patients. These profibrotic factors were found able to drive the cross-talk between structural (epithelium and FBs) and inflammatory (lymphocytes, eosinophils, and mast cells) cells. This cell-factor interaction contributes to the chronic inflammatory process, giant papillae formation and tissue remodeling, as observed in VKC [2,3,5,21-23]. Among these, TGFbeta1 isoform remains the main pro-fibrogenic factor, being responsible for ECM ex-novo deposition, the inhibition of ECM degradation and the prolonged myoFB activity [24].
###end p 54
###begin p 55
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
NGF is also increased in VKC blood and conjunctiva as a result of the activation of both structural (epithelium and FBs) and inflammatory cells (Th2 lymphocytes, mast cells, and eosinophils), during the active conjunctivitis [7,22]. Older and more recent data [8,22-24] indicate that NGF is a pleiotrophic factor participating to the control of inflammatory responses, tissue repair, fibrosis, and remodeling in different tissues. Primary cultures of healthy-FBs have been found to be modulated by NGF with relation to cell migration, differentiation, and contraction of a cell matrix [8].
###end p 55
###begin p 56
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
Since stromal FBs represent the major target/effector cells involved in tissue remodeling [6,12,25] and since NGF activates in vitro healthy-FBs [8,26,27], we sough to evaluate the possible modulation of FBs isolated from conjunctiva of patients with VKC by NGF, hence no data are available in literature.
###end p 56
###begin p 57
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 262 266 254 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 303 306 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 445 446 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 681 684 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 702 710 686 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 886 890 870 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 932 935 916 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1007 1010 991 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1273 1277 1257 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 1281 1284 1265 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 1309 1310 1293 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 1311 1313 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
In the present study, increased expression of NGF, associated with increased expression of p75NTR and alphaSMA, was detected in VKC-FBs as compared with conjunctival healthy-FBs. In addition, alphaSMA was found expressed in FBs showing light upregulation of trkANGFR and considerable upregulation of p75NTR, suggesting a specific role for NGF in VKC-FBs. In line with the effect of NGF in driving the differentiation of healthy FBs into myoFBs [8], we wondered whether NGF supplementation to VKC-FBs cultures would result in a further VKC-FB differentiation, evaluated as alphaSMA expression. Interestingly, NGF failed to further increase alphaSMA expression in VKC-FBs, unless p75NTR was blocked (see Figure 2; light bars). This data is of great interest, since it suggests two possible hypothesis: (1) NGF plays a differentiating effect through the specific and unique binding to trkANGFR (NGF is a specific receptor), but not p75NTR (the pan-neurotrophin receptor); and (2) the specific expression of p75NTR, by myoFB phenotype (otherwise absent in FBs), seems to play a switch-off effect in the further differentiating action of NGF, suggesting that NGF plays a modulatory rather than a exclusive stimulatory effect on the fibrotic process. The answer might lie in trkANGFR/p75NTR multifaceted functions [7,22].
###end p 57
###begin p 58
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 846 847 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
On the other side in VKC tissue remodeling process, NGF might modulate collagen production and might influence MMP2/MMP9 production/activity, as previously demonstrated for other growth factors [2,4]. ECM metabolism is heavily impaired in VKC, due to a substantial increase in total collagen deposition in the conjunctiva (mainly types I, III, and IV), and an increased release of MMP2/MMP9 in the tears [3,4]. In this study, the expression of type-I collagen decreased significantly after NGF exposure, rather quite specific given that this effect was not observed for type-IV collagen or with the addition of TGFbeta1 (data not shown). In addition, NGF was able to induce specifically MMP9 expression/activity by VKC-FBs at both molecular, biochemical and functional levels. This effect was not observed in healthy-FBs, as previously reported [8].
###end p 58
###begin p 59
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 870 874 870 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 878 881 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
###xml 938 942 938 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGFR</sup>
###xml 1012 1015 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NTR</sup>
Taken together, these data suggest a many-sided role of NGF in VKC tissue remodeling. NGF is increased in VKC blood and tarsal conjunctiva and likewise in tears [9]. In in vitro studies, NGF induces the differentiation of healthy conjunctival FBs into myoFBs, the main effector and target cells of fibrotic process. This differentiating effect was not observed in VKC-derived conjunctival FBs in the present study. Additionally, NGF induced a decrease in type I collagen and an increase in MMP9 expression by VKC-FBs with no specific effect on both MMP1 and MMP2 mRNA expression. It has been previously reported that both MMP2 and MMP9 degrade types IV and V collagen; MMP9 can also degrade types I and type III collagen [28,29]. One possible explanation for these data might be related to the well-known singular action of NGF due to changes in the balance between trkANGFR/p75NTR expression. In this study we demonstrated a role of trkANGFR in the differentiating effect of NGF on FBs; however, the role of p75NTR on VKC-FB function seems complex and remains to be elucidated.
###end p 59
###begin p 60
In VKC, various growth factors and Th2-cytokines are produced by inflammatory/stromal cells. In line with other studies, these factors have been proposed to modulate tissue remodeling in VKC. To summarize, our in vitro findings showing the NGF modulation of both type I collagen and MMP9, might propose NGF as an active contributor in VKC remodeling.
###end p 60
###begin title 61
Acknowledgements
###end title 61
###begin p 62
This study was presented in part at the 2005 Association for Research in Vision and Ophthalmology meeting in Fort Lauderdale, Florida. Many thanks to Dr. G. Lapucci, from the Institute of Neurobiology and Molecular Medicine (Italian National Research Council, CNR, Rome, Italy), for technical assistance in some experiments.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis.
###end article-title 64
###begin article-title 65
Growth factors and collagen distribution in vernal keratoconjunctivitis.
###end article-title 65
###begin article-title 66
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
###end article-title 66
###begin article-title 67
Vernal keratoconjunctivitis: pathogenesis and treatment.
###end article-title 67
###begin article-title 68
Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling.
###end article-title 68
###begin article-title 69
Tissue repair, contraction, and the myofibroblast.
###end article-title 69
###begin article-title 70
New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis.
###end article-title 70
###begin article-title 71
The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta.
###end article-title 71
###begin article-title 72
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells.
###end article-title 72
###begin article-title 73
Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation.
###end article-title 73
###begin article-title 74
The nerve growth factor: purification as a 30,000-molecular-weight protein.
###end article-title 74
###begin article-title 75
Normal scarring: importance of myofibroblasts.
###end article-title 75
###begin article-title 76
Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human corneal endothelial cell proliferation: potential for use in regenerative medicine.
###end article-title 77
###begin article-title 78
An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues.
###end article-title 78
###begin article-title 79
A quantitative bioassay for nerve growth factor (NGF) activity employing a clonal pheochromocytoma cell line.
###end article-title 79
###begin article-title 80
###xml 48 53 <span type="species:ncbi:9606">human</span>
Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4.
###end article-title 80
###begin article-title 81
###xml 82 87 <span type="species:ncbi:9606">human</span>
Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices.
###end article-title 81
###begin article-title 82
Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis.
###end article-title 82
###begin article-title 83
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.
###end article-title 83
###begin article-title 84
Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases.
###end article-title 84
###begin article-title 85
###xml 30 35 <span type="species:ncbi:9606">human</span>
Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing.
###end article-title 85
###begin article-title 86
Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases.
###end article-title 86
###begin article-title 87
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.
###end article-title 87
###begin article-title 88
###xml 52 57 <span type="species:ncbi:9606">human</span>
Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair.
###end article-title 88
###begin article-title 89
Nerve growth factor stimulates fibronectin-induced fibroblast migration.
###end article-title 89
###begin article-title 90
Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
###end article-title 90
###begin article-title 91
###xml 80 85 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
###end article-title 91

